AbCellera Biologics (NASDAQ:ABCL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does AbCellera Biologics (ABCL) operate in?

AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.

Open	$2.70
Close	$2.85
Volume / Avg.	2.08M / 2.26M
Day Range	$2.68 - $2.88
52 Wk Range	2.34 - 6.06
Market Cap	$827.03M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	7.14%
Days to Cover	7.36

Recent News

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects

Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ: ABCL),

Nabaparna Bhattacharya

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.70
Close	$2.85
Volume / Avg.	2.08M / 2.26M
Day Range	$2.68 - $2.88
52 Wk Range	2.34 - 6.06
Market Cap	$827.03M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	7.14%
Days to Cover	7.36

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AbCellera Biologics (ABCL) stock?

You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.

View our list of the best stock brokerages

Who are AbCellera Biologics (ABCL) competitors?

Other companies in AbCellera Biologics’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Sotera Health (NASDAQ:SHC) and Quanterix (NASDAQ:QTRX).

What is the forecast, or price target, for AbCellera Biologics (ABCL) stock?

AbCellera Biologics has a consensus price target of $21.11.

What is the current price for AbCellera Biologics (ABCL)?

The stock price for AbCellera Biologics (NASDAQ: ABCL) is $2.8 last updated December 20, 2024 at 6:39 PM EST.

Does AbCellera Biologics (ABCL) pay a dividend?

There are no upcoming dividends for AbCellera Biologics.

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

AbCellera Biologics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.

Is AbCellera Biologics (ABCL) going to split?

There is no upcoming split for AbCellera Biologics.

What sector and industry does AbCellera Biologics (ABCL) operate in?

AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Comments

AbCellera Biologics

AbCellera Biologics (ABCL) Forecast